US 6812216
11-C-substituted derivatives of clarithromycin
expired A61KA61K31/70
Quick answer
US patent 6812216 (11-C-substituted derivatives of clarithromycin) held by Enanta Pharmaceuticals, Inc. expires Mon Oct 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Nov 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/70